14
Views
0
CrossRef citations to date
0
Altmetric
Session I: Physiological Aspects on ACE Inhibitors

Competitive Inhibitor Binding Assay (IBA) of Captopril and Other Inhibitors of Angiotensin Converting Enzyme

&
Pages 13-16 | Published online: 27 Oct 2016

References

  • Rubin B., Antonaccio MJ. Captopril. In: Scriabine A. ed. Pharmacology of antihypertensive drugs. New York, Raven Press 21–42, 1980
  • Patchett A. The design of enalapril. In: Doyle A.E., Bearn AG, eds. Hypertension and the angiotensin system: Therapeutic approaches. New York, Raven Press 155–165, 1984
  • Duchin K.L., Singhvi S.M., Willard D.A., Migdal of B.H., McKinstry DN. Captopril kinetics. Clin. Pharmacol. Ther. 31: 452–58, 1982
  • Matsuki Y., Ito T., Fukuhara K., Nakamura T., Kimura M., Ono H. Determination of captopril and its disulphide in biological fluids. J. Chromatography 239: 585–94, 1982
  • Koike H., Ikeda T., Komai T., Kawai K., Miyamoto M., Shindo H. Relationship between inhibition of pressor response to angiotensin I and blood concentration of captopril following a single oral administration to dogs. Eur. J. Pharmacol. 69: 447:51, 1981
  • Cody R.J., Schaer G.L., Covit A.B., Pondolfino K., Williams G. Captopril kinetics in chronic congestive heart failure. Clin. Pharmacol. 32: 721–26, 1982
  • Onoyama K., Hirakata H., Iseki K., Fujimi S., Omae T., Kobayashi M., Kawahara Y. Blood concentration and urinary excretion of captopril (SO 14,225) in patients with chronical renal failure. Hypertension 3: 456–459, 1981
  • Duncan E.M., Martin V.I.., Williams B.C., Al-Dujaili E.A.S., Edwards R.W. Development and optimisation of a radioimmunoassay for plasma captopril. Clin. Chem. Acta 295–303, 1983
  • Fyhrquist E., Tikkanen L., Grönhagen-Riska C., Hortling L., Hichens M. Inhibitor binding assay for Angiotension-Converting Enzyme. Clin. Chem. 30, 696–700 1984
  • Swanson B.N., Hichens M., Mojaverian P. Angiotensin converting enzyme activity in human serum: Relationship to enzyme inhibitor in vivo and in vitro. Res. Commun. Chem. Pathol. Pharmacol. 33: 525–36, 1981
  • Biollaz J., Schelling J.L., Jacot des Combes B., Brunner D.B., Desponds G., Brunner H.R. Enalapril maleate and a lysine analogue (MK–521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system. Brit. J. Pharmacol. 14:363–68, 1982
  • Funae Y., Komori T., Sasaki D., Yamamoto K. Inhibitor of angiotensin converting enzyme: (4R)-3-(2S)-3-mercapto-2-methylpropanoyl-4-thiazolidinecarboxylic acid (YS 980). Biochem. Pharmacol. 29: 1543–47, 1980
  • Boomsma F., de Bruyn J.H.B., Derkx F.H.M., Schalekamp M.A.D. Opposite effects of captopril on angiotensin converting enzyme "activity" and "concentration"; relation between enzyme inhibition and long-term blood pressure responses. Clin. Science 60: 491–98, 1981
  • Fyhrquist F., Grönhagen-Riska C., Hortling L., Forslund T., Tikkanen L., Klockars M. The induction of angiotensin converting enzyme by its inhibitors. Clin. Exp. Hypertension A5 (7&8): 1319–1330, 1983
  • Fyhrquist F., Grönhagen-Riska C., Hortling L., Forslund T., Tikkanen I. Regulation of angiotensin converting enzyme. J. Hypertension 1 (Suppl 1): 25–30, 1983

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.